Group 1 - The core viewpoint of the article highlights the significant stock price increase of Brainstorm Aurora (06681), which rose over 50% to reach a new high of 9.47 HKD following its inclusion in the Hong Kong Stock Connect program effective September 8, 2025 [1] - As of the report, the stock was trading at 8.52 HKD with a trading volume of 579 million HKD, reflecting strong market interest [1] - The company reported a revenue of 100 million HKD for the first half of 2025, representing a year-on-year increase of 92.82% [1] Group 2 - The company has made significant advancements in its core pipeline in research and clinical trials, achieving commercialization for eight indications across four major types of cognitive disorders [1] - Additionally, the company is actively developing treatments for other cognitive disorder indications [1] - The company is pushing for innovation and application of AI in the medical field, having developed a proprietary medical large model, BrainAuGPT, which received a national invention patent for its novel training task combination method based on GBR second-order knowledge representation [1]

智通财经APP获悉，脑动极光(06681)涨超50%，高见9.47港元创上市新高。截至发稿，涨50.44%，报 8.52港元，成交额5.79亿港元。 消息面上，沪深交易所发布公告，调整港股通标的证券名单，其中，脑动极光获纳入港股通，2025年9 月8日起生效。公司此前发布的2025年中期业绩显示，期内集团取得收入1亿元，同比增加92.82% 公司指出，今年上半年核心管线在科研及临床试验方面取得重大进展，核心产品已就四种主要类型认知 障碍的八种适应症实现商业化，并正就其他几种认知障碍适应症进行开发。另外，公司还不断推动AI 在医疗领域的创新和应用，自主研发的医疗大模型BrainAuGPT，首次提出的基于GBR二阶知识表达的 大语言模型的训练任务组合推荐方法获得国家发明专利授权。 ...